Berberine decreases cell growth but increases the side population fraction of H460 lung cancer cells Authors
First Online: 31 August 2012 Received: 28 May 2012 Accepted: 12 June 2012 DOI:
Cite this article as: Sung, J.H., Kim, J.B., Park, S.H. et al. J Korean Soc Appl Biol Chem (2012) 55: 491. doi:10.1007/s13765-012-2119-0 Abstract
Berberine has been reported to inhibit tumor growth in lung cancer. Thus, the effects of berberine on cancer cells as well as the cancer stem cell (side population; SP) fraction were investigated in the H460 lung cancer cell line, and the effects of berberine treatment on cell growth, cell cycle, and cell death were evaluated. Changes in the SP fraction were examined after treatment with berberine, 5-fluorouracil (5-FU), and co-treatment. Berberine inhibited cancer cell growth in a dose-dependent manner. Treatment of the cells with berberine resulted in a 4% increase in cell death and an 8% increase in the number of cells of G
0/G 1 phase, compared to the untreated control. To examine the relationship between berberine and cancer stem cells, the SP fraction was analyzed. Surprisingly, the SP cell fraction was increased upon berberine treatment and further increased after cotreatment with 5-FU. These results are in contrast to the study of Kim et al. (2008) with MCF-7 breast cancer cells, in which berberine inhibited the growth of both cancer cells and the corresponding cancer stem cells. Results of the present study suggest that berberine should be used with caution in the treatment of various cancers, despite its positive effect on cancer cell growth inhibition. Keywords berberine cancer stem cells cell growth 5-fluorouracil lung cancer side population
J. H. Sung and J. B. Kim contributed equally.
Abe K, Shimizu R, Pan X, Hamada H, Yoshikawa H, and Yamamoto M (2009) Stem cells of GATA1-related leukemia undergo pernicious changes after 5-fluorouracil treatment.
, 435–445 e431.
Chikazawa N, Tanaka H, Tasaka T, Nakamura M, Tanaka M, Onishi H et al. (2010) Inhibition of Wnt signaling pathway decreases chemotherapyresistant side-population colon cancer cells.
Christgen M, Ballmaier M, Bruchhardt H, von Wasielewski R, Kreipe H, and Lehmann U (2007) Identification of a distinct side population of cancer cells in the Cal-51 human breast carcinoma cell line.
Mol Cell Biochem
Goodell MA, Brose K, Paradis G, Conner AS, and Mulligan RC (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
J Exp Med
Haraguchi N, Utsunomiya T, Inoue H, Tanaka F, Mimori K, Barnard GF et al. (2006) Characterization of a side population of cancer cells from human gastrointestinal system.
Harper LJ, Piper K, Common J, Fortune F, and Mackenzie IC (2007) Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma.
J Oral Pathol Med
Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U et al. (2004) A distinct “side population” of cells with high drug efflux capacity in human tumor cells.
Proc Natl Acad Sci USA
Ho YT, Yang JS, Lu CC, Chiang JH, Li TC, Lin JJ et al. (2009) Berberine inhibits human tongue squamous carcinoma cancer tumor growth in a murine xenograft model.
Huang D, Gao Q, Guo L, Zhang C, Jiang W, Li H et al. (2009) Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines.
Stem Cells Dev
Jantova S, Letasiova S, Brezova V, Cipak L, and Labaj J (2006) Photochemical and phototoxic activity of berberine on murine fibroblast NIH-3T3 and Ehrlich ascites carcinoma cells.
J Photochem Photobiol B
Katiyar SK, Meeran SM, Katiyar N, and Akhtar S (2009) p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells
and tumor xenograft growth in vivo.
Kim JB, Ko E, Han W, Shin I, Park SY, and Noh DY (2008) Berberine diminishes the side population and ABCG2 transporter expression in MCF-7 breast cancer cells.
Kim JB, Yu JH, Ko E, Lee KW, Song AK, Park SY et al. (2010) The alkaloid berberine inhibits the growth of Anoikis-resistant MCF-7 and MDAMB-231 breast cancer cell lines by inducing cell cycle arrest.
Lee HS, Kim BS, and Kim MK (2002) Suppression effect of
bark-derived component on nitric oxide synthase.
J Agric Food Chem
Leng SH, Lu FE, and Xu LJ (2004) Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion.
Acta Pharmacol Sin
Lin CC, Kao ST, Chen GW, Ho HC, and Chung JG (2006) Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3.
Liu Y, Lou SY, and He YM (2008) Effects of berberine on cell proliferation, peroxisome proliferation activated receptor gamma, CAAT/enhancer binding protein mRNA and protein expression in 3T3-L1 pre-adipocytes.
Zhongguo Zhong i Yi Jie He Za Zhi
Luo Y, Hao Y, Shi TP, Deng WW, and Li N (2008) Berberine inhibits cyclin D1 expression via suppressed binding of AP-1 transcription factors to CCND1 AP-1 motif.
Acta Pharmacol Sin
Meng X, Wang X, and Wang Y (2009) More than 45% of A549 and H446 cells are cancer initiating cells: evidence from cloning and tumorigenic analyses.
Mimeault M and Batra SK (2009) Characterization of nonmalignant and malignant prostatic stem/progenitor cells by Hoechst side population method.
Methods Mol Biol
Mitani N, Murakami K, Yamaura T, Ikeda T, and Saiki I (2001) Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotopic implantation of Lewis lung carcinoma.
Oates JE, Grey BR, Addla SK, Samuel JD, Hart CA, Ramani VA et al. (2009) Hoechst 33342 side population identification is a conserved and unified mechanism in urological cancers.
Stem Cells Dev
Pandey MK, Sung B, Kunnumakkara AB, Sethi G, Chaturvedi MM, and Aggarwal BB (2008) Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
Peng PL, Hsieh YS, Wang CJ, Hsu JL, and Chou FP (2006) Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2.
Toxicol Appl Pharmacol
Reya T, Morrison SJ, Clarke MF, and Weissman IL (2001) Stem cells, cancer, and cancer stem cells.
Sauna ZE, Shukla S, and Ambudkar SV (2005) Disulfiram, an old drug with new potential therapeutic uses for human cancers and fungal infections.
Shen G, Shen F, Shi Z, Liu W, Hu W, Zheng X et al. (2008) Identification of cancer stem-like cells in the C6 glioma cell line and the limitation of current identification methods.
In Vitro Cell Dev Biol Anim
Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R et al. (2006) Ovarian cancer side population defines cells with stem cell-like characteristics and mullerian inhibiting substance responsiveness.
Proc Natl Acad Sci USA
Yang M, Zhang R, Yan M, Ye Z, Liang W, and Luo Z (2010) Detection and characterization of side population in Ewing’s sarcoma SK-ES-1 cells in vitro.
Biochem Biophys Res Commun
Yajima T, Ochiai H, Uchiyama T, Takano N, Shibahara T, and Azuma T (2009) Resistance to cytotoxic chemotherapy-induced apoptosis in side population cells of human oral squamous cell carcinoma cell line Ho-1-N-1.
Int J Oncol
35, 273–280. Copyright information
© The Korean Society for Applied Biological Chemistry 2012